plantamajoside
plantamajoside Basic information
- Product Name:
- plantamajoside
- Synonyms:
-
- plantamajoside
- b-D-Glucopyranoside,2-(3,4-dihydroxyphenyl)ethyl 3-O-b-D-glucopyranosyl-, 4-[(2E)-3-(3,4-dihydroxyphenyl)-2-propenoate]
- 2-(3,4-Dihydroxyphenyl)ethyl 4-O-(3,4-dihydroxycinnamoyl)-3-O-(β-D-glucopyranosyl)-β-D-glucopyranoside
- Plantamoside
- 2-(3,4-Dihydroxyphenyl)ethyl 3-O-beta-D-glucopyranosyl-beta-D-glucopyranoside 4-[(2E)-3-(3,4-dihydroxyphenyl)-2-propenoate]
- Purpureaside A
- (E)-6-(3,4-Dihydroxyphenethoxy)-5-hydroxy-2-(hydroxymethyl)-4-((3,4,5-trihydroxy-6-(hydroxymet
- dihoside A
- CAS:
- 104777-68-6
- MF:
- C29H36O16
- MW:
- 640.59
- Product Categories:
-
- chemical reagent
- pharmaceutical intermediate
- phytochemical
- reference standards from Chinese medicinal herbs (TCM).
- standardized herbal extract
- Mol File:
- 104777-68-6.mol
plantamajoside Chemical Properties
- Boiling point:
- 953.0±65.0 °C(Predicted)
- Density
- 1.66
- storage temp.
- 2-8°C
- solubility
- Soluble in methanol and water
- form
- powder
- pka
- 9.31±0.10(Predicted)
- color
- White
- InChIKey
- KFEFLPDKISUVNR-ILWPCWSYNA-N
Safety Information
- Safety Statements
- 24/25
- HS Code
- 29389090
plantamajoside Usage And Synthesis
Chemical Properties
White crystalline powder, easily soluble in methanol, derived from plantain.
Uses
food and beverages
Definition
ChEBI: Plantamajoside is a hydroxycinnamic acid.
in vivo
Plantamajoside (20-80 mg/kg) promotes the recovery of neurological function and protects the tissue structure of the spinal cord after ASCI in a rat model of acute spinal cord injury[15].
Plantamajoside (25-100 mg/kg, i.p., 24 h) alleviates acute sepsis-induced organ dysfunction through inhibiting the TRAF6/NF-κB axis in mice[16].
Plantamajoside (10-40 mg/kg, p.o., 4 weeks) has protective activities against Cd-induced renal injury in rats[17].
Plantamajoside (25-100 mg/kg, i.p., three times at 6, 12, 18 h) ameliorates lipopolysaccharide-induced acute lung injury via suppressing NF-κB and MAPK activation in mice[18].
Plantamajoside (20-80 mg/kg, i.p., once a day for 4 weeks) modulates immune dysregulation and hepatic lipid metabolism in rats with nonalcoholic fatty liver disease via AMPK/Nrf2 elevation[19].
| Animal Model: | Acute sepsis C57BL/6 male mice model by caecal ligation and perforation (CLP)[16] |
| Dosage: | 25, 50, 100 mg/kg |
| Administration: | Intraperitoneal injection (i.p.), 24 h |
| Result: | Extended survival in CLP model. Improved acute sepsis-triggered organ damage. Alleviated acute sepsis-triggered apoptosis. Relieved acute sepsis-triggered inflammatory response. Improved acute sepsis-triggered organ damage via mediating the TRAF6/NF-κB pathway. Improved acute sepsis-triggered apoptosis and inflammation via regulating the TRAF6/NF-κB pathway. |
plantamajosideSupplier
- Tel
- 2355253622; 18981954830
- 2355253622@qq.com;
- Tel
- +86-21-20908456
- sales@BioChemBest.com
- Tel
- 400-1166-196 18981987031
- cdhxsj@163.com
- Tel
- +86-0755-89668383
- sales@sungening.com
- Tel
- 0411-62910999 13889544652
- sales@meilune.com
plantamajoside(104777-68-6)Related Product Information
- Deslanoside
- Verbascoside
- CYNARIN
- 1-Caffeoylquinic acid
- 2'-acetylacteoside
- 4-Allylpyrocatechol
- 3-O-GalloylMucic acid
- 3,4-Dihydroxyphenethyl 3-O-β-D-glucopyranosyl-6-O-(3,4-dihydroxycinnamoyl)-β-D-glucopyranoside
- CYNARIN
- 1,3,5-Tricaffeoylquinic acid
- 2,3,4,5-Tetracaffeoyl-D-Glucaric acid
- plantagoside
- 6-Methoxysalicylic acid
- Cynarin
- Swertiamarine
- MONOCROTALINE
- Taxifolin
- Hydroxysafflor yellow A